series-b
Stage
4
Investors
About
Adicet Bio is a clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.
Explore Adicet Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.